2012
DOI: 10.1016/j.neuroscience.2012.09.030
|View full text |Cite
|
Sign up to set email alerts
|

Dopamine receptor inactivation in the caudate-putamen differentially affects the behavior of preweanling and adult rats

Abstract: The irreversible receptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) has been used to study the ontogeny of dopamine (DA) receptor functioning in the young and adult rat. Most notably, systemic administration of EEDQ blocks the DA agonist-induced behaviors of adult rats, while leaving the behavior of preweanling rats unaffected. The purpose of the present study was to: (a) determine whether the age-dependent actions of EEDQ involve receptors located in the dorsal caudate-putamen (CPu) and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
35
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(38 citation statements)
references
References 68 publications
3
35
0
Order By: Relevance
“…In adolescent and adult rats, EEDQ minimally elevates the percentage of D2 High receptors while attenuating DA agonist-induced behaviors (Der Ghazarian et al 2012; McDougall et al 2014b). Microinjecting EEDQ into the striatum of preweanling rats, on the other hand, significantly reduces D2 receptor densities, increases the percentage of D2 High receptors, and potentiates cocaine-induced locomotor activity (Der Ghazarian et al 2012, 2014; McDougall et al 2014b). Thus, EEDQ-induced increases in D2 High receptors appear to enhance behavioral sensitivity to cocaine and other DA agonists.…”
Section: Discussionmentioning
confidence: 99%
“…In adolescent and adult rats, EEDQ minimally elevates the percentage of D2 High receptors while attenuating DA agonist-induced behaviors (Der Ghazarian et al 2012; McDougall et al 2014b). Microinjecting EEDQ into the striatum of preweanling rats, on the other hand, significantly reduces D2 receptor densities, increases the percentage of D2 High receptors, and potentiates cocaine-induced locomotor activity (Der Ghazarian et al 2012, 2014; McDougall et al 2014b). Thus, EEDQ-induced increases in D2 High receptors appear to enhance behavioral sensitivity to cocaine and other DA agonists.…”
Section: Discussionmentioning
confidence: 99%
“…Corrected degrees of freedom were rounded to the nearest whole number and are indicated by a superscripted “a”. Prepubescent rats, unlike young mice (Laviola et al, 1994), do not typically exhibit sex differences after DA agonist treatment (Frantz et al, 1996; Bowman et al, 1997; Snyder et al, 1998; Der-Ghazarian et al, 2012). Consistent with these past rat studies, distance traveled data did not differ according to sex, so this variable was not included in the final statistical analyses.…”
Section: Methodsmentioning
confidence: 99%
“…In terms of behavioral responsiveness, for example, preweanling and adult rats respond in a nearly opposite manner after pharmacologically-induced DA receptor inactivation. More specifically, microinjecting the irreversible receptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) into the CPu depresses the basal locomotor activity of adult rats, while increasing the locomotion of preweanling rats (Der-Ghazarian et al 2012). This unusual ontogenetic effect is even more prominent after treatment with a nonselective DA receptor agonist, because EEDQ-treated preweanling rats given R-propylnorapomorphine (NPA) infusions into the CPu exhibit significantly more locomotor activity than rats treated with NPA alone (Der-Ghazarian et al 2012).…”
Section: Introductionmentioning
confidence: 99%